Pay in 4 interest-free payments of $26.25 Learn more
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7
InChiKey: IHIUGIVXARLYHP-UXNJHFGPSA-N
Ba/F3-TEL-TRKC (IC50 of 3
p) significantly reverses formalin-induced impaired hippocampal-dependent behavior
a potent and selective CRTh2 receptor antagonist suitable for clinical testing in allergic diseases
Tegatrabetan (BC2059) is an antagonist of β-Catenin
RAF265 enafil dihydrochloride InChiKey: IHIUGIVXARLYHP-UXNJHFGPSA-NCHIR 265 is an orally bioavailable small molecule with potential antineoplastic activity. CHIR 265 binds and inhibits Raf kinases, which may result in a reduction of tumor cell growth and proliferation, and tumor cell death. In addition, this agent inhibits vascular endothelial growth factor receptor type 2 (VEGFR 2), thereby disrupting tumor angiogenesis. Raf kinases are critical enzymes in the Ras Raf MEK ERK signaling pathway and are frequently